Galway Biomedical
Series A in 2025
Galway Biomedical specializes in the development and manufacturing of medical devices, focusing primarily on surgical implants. Their product portfolio spans various clinical fields, including vascular, dental, orthopaedic, urology, and general surgery, contributing to advancements in biomaterial-based medical device implants.
Ovagen is a biotechnology company specializing in the production of germ-free (GF) chicken eggs and GF birds in commercial quantities, primarily for the pharmaceutical industry. The company has developed a unique process that enables large-scale production of recombinant proteins to Good Manufacturing Practice (GMP) standards using a transgenic chicken platform. This innovative approach provides pharmaceutical companies with a biosecure, flexible, and cost-effective biomanufacturing solution for vaccines and therapeutic proteins. In addition to its core production capabilities, Ovagen offers Contract Research Services and possesses extensive expertise in specific poultry and rodent research technologies, as well as in the housing and husbandry of specific pathogen-free (SPF) poultry and rodents.
Peroptyx
Seed Round in 2024
Peroptyx is a company that specializes in providing location-based machine learning training data and model evaluation solutions for global technology brands. Its platform is designed to deliver high-quality training data and ensure accurate model evaluation through the integration of personalized authentication, onboarding, and performance analytics. By leveraging unique innovations in data security, geo-location, and identity, Peroptyx aims to minimize bias and errors in machine learning training data. This enables product and data science leaders to obtain high-fidelity, locally relevant data essential for training algorithms across various applications, including maps, search, music, voice, and generative artificial intelligence services. Peroptyx's solutions are tailored to meet the needs of consumer-facing organizations, allowing them to deploy reliable models more efficiently.
CitySwift
Venture Round in 2024
CitySwift is a technology company based in Galway, Ireland, specializing in data-driven scheduling and planning for urban bus networks. Founded in 2016 by Alan Farrelly and Brian O'Rourke, CitySwift utilizes artificial intelligence and machine learning to predict journey times and passenger demand, enhancing route efficiency. The company's platform analyzes historical patterns to understand the impact of factors such as weather, traffic, and events on routes, cycle times, and patronage. This enables schedulers to create optimized timetables that ensure on-time performance and increased passenger satisfaction while helping bus operators improve network efficiency.
FeelTect
Venture Round in 2023
FeelTect is a medical device company based in Galway, Ireland, founded in 2019. The company specializes in developing connected-health technology, specifically a pressure sensing device known as Tight Alright. This device is designed to measure and monitor sub-bandage pressure during compression therapy, which is crucial for treating venous leg ulcers (VLUs). Effective compression is essential; if the pressure is too loose, it fails to provide therapeutic benefits, while excessive pressure can pose serious risks. FeelTect's technology enables users to view live readings and recorded data, facilitating optimal and individualized treatment regimens. By improving the application and maintenance of safe sub-bandage pressure, FeelTect aims to enhance patient outcomes and reduce the associated health-economic burden.
Amara Therapeutics
Seed Round in 2023
Amara Therapeutics is a company focused on enhancing pelvic health for both women and men through a digital therapeutic platform. It leverages evidence-based medicine and behavioral interventions to create safe, convenient, and non-invasive care pathways for patients. The platform facilitates the tracking of patient-specific conditions and treatment strategies while offering pelvic floor muscle training and expert-led education on pelvic and bladder health. By connecting healthcare providers, patients, and peers, Amara Therapeutics aims to improve the care pathway for pelvic health patients, ensuring they receive affordable and effective treatment options.
Bluedrop Medical
Venture Round in 2023
Bluedrop Medical, established in 2014 and headquartered in Galway, Ireland, specializes in the development, manufacturing, and commercialization of an IoT-enabled device for early detection of diabetic foot ulcers. Their home-based system scans patients' feet daily, transmitting data to the cloud for analysis via advanced algorithms, which can identify skin abnormalities. This innovation aims to reduce the risk of amputation and improve the lives of diabetic patients, with a significant global market given the high prevalence of diabetic foot ulcers.
ByoWave
Seed Round in 2023
ByoWave is a company that specializes in creating inclusive gaming experiences through its innovative video game controller, the Proteus Controller. This modular controller is designed to accommodate both disabled and non-disabled gamers, featuring a unique 'snap and play' system that allows users to easily connect various components. ByoWave's approach enables gamers to customize their controller configurations online, facilitating sharing and collaboration within the gaming community. The Proteus Controller is compatible with popular gaming platforms, including Xbox and PC, ensuring a versatile solution for a diverse audience.
Ovagen
Venture Round in 2023
Ovagen is a biotechnology company specializing in the production of germ-free (GF) chicken eggs and GF birds in commercial quantities, primarily for the pharmaceutical industry. The company has developed a unique process that enables large-scale production of recombinant proteins to Good Manufacturing Practice (GMP) standards using a transgenic chicken platform. This innovative approach provides pharmaceutical companies with a biosecure, flexible, and cost-effective biomanufacturing solution for vaccines and therapeutic proteins. In addition to its core production capabilities, Ovagen offers Contract Research Services and possesses extensive expertise in specific poultry and rodent research technologies, as well as in the housing and husbandry of specific pathogen-free (SPF) poultry and rodents.
CitySwift
Series A in 2022
CitySwift is a technology company based in Galway, Ireland, specializing in data-driven scheduling and planning for urban bus networks. Founded in 2016 by Alan Farrelly and Brian O'Rourke, CitySwift utilizes artificial intelligence and machine learning to predict journey times and passenger demand, enhancing route efficiency. The company's platform analyzes historical patterns to understand the impact of factors such as weather, traffic, and events on routes, cycle times, and patronage. This enables schedulers to create optimized timetables that ensure on-time performance and increased passenger satisfaction while helping bus operators improve network efficiency.
Signum Surgical
Venture Round in 2022
Signum Surgical Limited is a medical technology company based in Galway, Ireland, founded in 2014 by Eoin Bambury and Moshe Zilversmit. The company specializes in developing innovative solutions for the treatment of perianal fistulas, which are small tunnels that form between the end of the bowel and the skin near the anus. Signum Surgical's primary product is a bio-absorbable implant designed to be used post-surgery, facilitating the closure and healing of the fistula tract. This implant dissolves within the body after treatment and helps prevent reinfection, thereby promoting a faster healing process. The company's focus on addressing the lack of innovation in this area aims to enhance the effectiveness of care for patients suffering from colorectal conditions.
3D Issue
Venture Round in 2022
3D Issue is a publishing platform that specializes in designing and deploying interactive digital editions, content centers, and branded applications. The company offers a content creation platform that facilitates the development of mobile-centric and responsive content experiences for various devices. Its services include an integrated loader that enhances the speed of conversion and publication, as well as analytics tools that allow users to monitor reader engagement and refine their content offerings. Additionally, 3D Issue provides built-in sharing functionality, enabling users to efficiently create and distribute multi-screen digital publications across multiple digital channels.
Hooke Bio
Seed Round in 2022
Hooke Bio Ltd. is a biotechnology company based in Shannon, Ireland, focused on developing microfluidic technologies for drug screening and related applications. Founded in 2014, the company has created a fully integrated high-throughput screening system that utilizes 3D microtissues, such as spheroids and organoids, to generate biological data. This innovative, patent-protected technology aims to reduce reliance on animal models in preclinical studies and accelerate the drug development process. By enabling pharmaceutical companies and clinicians to develop more accurate disease models and optimize treatments based on individual patient samples, Hooke Bio enhances the ability to test and repurpose drugs effectively, ultimately improving patient care and outcomes.
Versono Medical
Venture Round in 2022
Versono Medical is an early stage Irish MedTech company located in Galway, a global centre for excellence in medical technologies. The company collaborates with clinicians and research institutions across the world.
FeelTect
Seed Round in 2022
FeelTect is a medical device company based in Galway, Ireland, founded in 2019. The company specializes in developing connected-health technology, specifically a pressure sensing device known as Tight Alright. This device is designed to measure and monitor sub-bandage pressure during compression therapy, which is crucial for treating venous leg ulcers (VLUs). Effective compression is essential; if the pressure is too loose, it fails to provide therapeutic benefits, while excessive pressure can pose serious risks. FeelTect's technology enables users to view live readings and recorded data, facilitating optimal and individualized treatment regimens. By improving the application and maintenance of safe sub-bandage pressure, FeelTect aims to enhance patient outcomes and reduce the associated health-economic burden.
Bluedrop Medical
Venture Round in 2021
Bluedrop Medical, established in 2014 and headquartered in Galway, Ireland, specializes in the development, manufacturing, and commercialization of an IoT-enabled device for early detection of diabetic foot ulcers. Their home-based system scans patients' feet daily, transmitting data to the cloud for analysis via advanced algorithms, which can identify skin abnormalities. This innovation aims to reduce the risk of amputation and improve the lives of diabetic patients, with a significant global market given the high prevalence of diabetic foot ulcers.
Tympany Medical
Seed Round in 2021
Tympany Medical is a company focused on advancing minimally invasive ear surgeries through innovative technology. It has developed a specialized ear surgery device that facilitates sterile endoscopy in the field of otolaryngology. This device addresses the challenges associated with traditional endoscopes, enhancing usability and flexibility for surgeons. By enabling effective endoscopic visualization, Tympany's technology allows surgeons to perform complex ear procedures while preserving their two-handed operating technique. The company's mission is to reduce the need for unnecessary mastoidectomies and improve surgical outcomes for patients undergoing ear surgery.
Content Llama
Seed Round in 2021
Content Llama Limited is a Donegal, Ireland-based company established in 2019 that operates a digital content platform designed to connect brands with retailers, specifically in the online sports, outdoor fashion, and pharmacy sectors. The platform automates the collection, configuration, and delivery of multi-source product content, including descriptions and images, tailored to the specific needs of eCommerce retailers. By utilizing advanced Content Configuration Technology and a dedicated team, Content Llama serves as a digital content gateway, sourcing, organizing, and transforming product information into formats compatible with retailers' internal systems such as PIM, DAM, CMS, and eCommerce platforms. This streamlined approach ensures that retailers receive high-quality, accurate product content, enhancing their online merchandising efforts and ultimately facilitating better customer engagement and sales conversions.
Locker
Pre Seed Round in 2021
Locker is a digital sports content platform that transforms how fans consume sports media through personalized experiences. Utilizing advanced machine learning and content aggregation, Locker allows users to access a wide array of topics and media brands from a single app. Fans can choose from hundreds of trusted sources and follow thousands of topics, enabling Locker to curate stories that align with their interests. The platform currently indexes over 1,500 sports publications and processes more than 5,000 articles daily, making it one of the leading aggregators in the sports media landscape. Initially focusing on written content, Locker plans to expand its offerings to include video and audio formats. The app is currently available in the UK and Irish app stores, providing users with real-time updates and customizable notifications to keep them engaged with their favorite teams.
Palliare is a medical technology company focused on advancing smoke insufflation and evacuation solutions tailored for various surgical applications, including robotic, laparoscopic, endoluminal, and colorectal procedures. The company offers products such as the EVA15 insufflator and a specialized smoke evacuation system, designed to enhance surgical workflows while safeguarding operating room staff from the dangers of surgical smoke and aerosolized viruses. Palliare aims to establish itself as a leader in the field of advanced insufflation technology, addressing the needs of minimally invasive surgery and providing hospitals with effective solutions for smoke management during surgical procedures.
Peroptyx
Seed Round in 2021
Peroptyx is a company that specializes in providing location-based machine learning training data and model evaluation solutions for global technology brands. Its platform is designed to deliver high-quality training data and ensure accurate model evaluation through the integration of personalized authentication, onboarding, and performance analytics. By leveraging unique innovations in data security, geo-location, and identity, Peroptyx aims to minimize bias and errors in machine learning training data. This enables product and data science leaders to obtain high-fidelity, locally relevant data essential for training algorithms across various applications, including maps, search, music, voice, and generative artificial intelligence services. Peroptyx's solutions are tailored to meet the needs of consumer-facing organizations, allowing them to deploy reliable models more efficiently.
Atlantic Therapeutics Limited
Venture Round in 2021
Atlantic Therapeutics Limited is a medical technology company based in Galway, Ireland, with additional offices in London, Paris, and Salem. Established in 2013, the company specializes in the manufacture and distribution of medical devices designed for pelvic floor muscle strengthening and nerve stimulation. Its key products include Innovotherapy, a device aimed at enhancing pelvic floor muscle function, and INNOVO, a wearable device specifically targeting stress urinary incontinence by addressing its underlying causes. Atlantic Therapeutics distributes its products through a network of distributors across Ireland, the United Kingdom, France, Germany, and the Middle East. The company operates as a subsidiary of Bio-Medical Research Limited.
InVera Medical
Seed Round in 2020
InVera Medical is focused on developing innovative medical devices aimed at treating varicose veins and venous ulcers. The company is creating BioVena™, a less invasive and pain-free treatment option that utilizes the body's natural biological response to address venous diseases. This proprietary technology positions InVera Medical to significantly improve patient outcomes by providing a safer and more effective alternative to existing treatment methods. With only a small fraction of the 120 million individuals suffering from venous disease receiving adequate endovenous treatment annually, InVera Medical seeks to broaden access to effective care for a population largely underserved by current solutions. The company’s advancements are particularly crucial given the high annual costs associated with venous ulcers, which amount to approximately $33 billion for insurers in the US and EU. By targeting the full spectrum of venous disease, InVera Medical aims to enhance the quality of life for patients who have long been limited to ineffective compression bandaging.
Fincovi
Seed Round in 2020
Fincovi is a technology company that offers specialized software applications and hosted solutions tailored for renewable energy companies. Its cloud-based financial services platform aims to enhance financial management, compliance, and insights, ultimately maximizing the value of energy portfolios. By leveraging advanced technology, Fincovi seeks to reduce operational costs associated with back- and middle-office functions in the renewable energy sector. The platform facilitates improved communication and information flow among stakeholders, enabling developers and fund managers to effectively build, originate, and fundraise for new projects. Through its open and connected ecosystem, Fincovi supports the growth and efficiency of renewable energy initiatives.
Cerebreon
Seed Round in 2020
Cerebreon Technologies Ltd., established in 2016 and based in Portnoo, Ireland, specializes in advanced data analytics, business management systems, and process automation. The company develops software solutions for the insolvency market, using machine learning and smart analytics to predict debt recovery outcomes, enhance efficiency, reduce costs, and ensure compliance. Cerebreon caters to businesses of all sizes and sectors, providing bespoke solutions and expert consultancy services to make high-end analytics accessible and beneficial to a wide range of enterprises.
A community project bridging the disconnect between remote work and local impact in rural area.
AtriAN Medical
Seed Round in 2019
AtriAN Medical is an Irish medical device company based in Galway, a prominent center for medical technology innovation. The company is focused on commercializing advanced technology developed at the Mayo Clinic in the United States. AtriAN specializes in a medical device designed to treat atrial fibrillation by employing micro Pulsed Electric Fields (mPEF). This innovative approach selectively ablates hyperactive tissue while preserving surrounding myocardium, minimizing damage to the heart muscle. Utilizing a catheter, AtriAN's device delivers short pulses of electrical energy directly to the problematic areas, offering a targeted treatment option that enhances patient safety and outcomes.
Bluedrop Medical
Seed Round in 2019
Bluedrop Medical, established in 2014 and headquartered in Galway, Ireland, specializes in the development, manufacturing, and commercialization of an IoT-enabled device for early detection of diabetic foot ulcers. Their home-based system scans patients' feet daily, transmitting data to the cloud for analysis via advanced algorithms, which can identify skin abnormalities. This innovation aims to reduce the risk of amputation and improve the lives of diabetic patients, with a significant global market given the high prevalence of diabetic foot ulcers.
Hooke Bio Ltd. is a biotechnology company based in Shannon, Ireland, focused on developing microfluidic technologies for drug screening and related applications. Founded in 2014, the company has created a fully integrated high-throughput screening system that utilizes 3D microtissues, such as spheroids and organoids, to generate biological data. This innovative, patent-protected technology aims to reduce reliance on animal models in preclinical studies and accelerate the drug development process. By enabling pharmaceutical companies and clinicians to develop more accurate disease models and optimize treatments based on individual patient samples, Hooke Bio enhances the ability to test and repurpose drugs effectively, ultimately improving patient care and outcomes.
Loci Orthopaedics
Seed Round in 2018
Loci Orthopaedics Limited, established in 2017 and headquartered in Upper Newcastle, Ireland, specialises in the manufacture of medical instruments, notably the InDx implant. This innovative device is designed to mimic natural thumb joint motions and offers a less invasive surgical solution for patients with arthritis in their thumb base joint, addressing a significant unmet clinical need in orthopaedics.
Neurent Medical
Seed Round in 2018
Neurent Medical Limited is a medical device company based in Galway, Ireland, founded in 2015 by Brian Shields and David Townley. The company specializes in developing non-surgical treatments for inflammatory sino-nasal diseases, specifically focusing on chronic rhinitis. Neurent Medical offers a single-use, minimally invasive device designed for ENT surgeons, which utilizes a hand-held radio-frequency mechanism. This device is introduced through the nostrils into the nasal cavity under direct endoscopic visualization, where it deploys a microelectrode array to deliver targeted energy. This intervention interrupts the autonomic function of the mucosal structures in the nasal cavities, effectively reversing the inflammatory cascade. By enabling treatment in an office setting, Neurent Medical aims to eliminate the complications and costs typically associated with traditional surgical procedures for rhinitis.
Kite Medical
Seed Round in 2018
Kite Medical, established in 2016 and headquartered in Galway, Ireland, specializes in the manufacture of a non-invasive, wearable device for detecting kidney reflux in children with urinary tract infections. This innovative solution aims to replace complex procedures and hospital visits, benefiting both patients and healthcare providers. The device targets a prevalent condition affecting up to 3% of young children, helping in early detection and preventing potential long-term kidney damage.
Neuravi Limited, established in 2009 and based in Galway, Ireland, specializes in designing and developing medical devices for treating acute ischemic strokes. The company's primary product, the EmboTrap revascularization device, is designed to restore blood flow by removing clots from blocked brain arteries. Neuravi operates in multiple European countries and is a subsidiary of DePuy Ireland Unlimited Company.
Embo Medical
Seed Round in 2014
Embo Medical, located at the National University of Ireland, is focused on developing innovative medical devices for vascular embolization. The company is creating the Caterpillar, a groundbreaking one-shot embolization device designed to enhance the efficiency and safety of peripheral vascular embolization procedures. This device aims to significantly reduce procedural times, enabling physicians to perform embolizations in a more cost-effective manner. With approximately 180,000 such procedures conducted annually worldwide, Embo Medical is positioned to make a meaningful impact in the medical field by improving patient outcomes and streamlining medical practices.
Good4U
Venture Round in 2014
Good4U is a company that specializes in the production and sale of nutritious sprouts and shoots, aimed at enhancing health and well-being. Established in 2004 by Bernie and her daughter Michelle, a certified dietitian and nutritionist, Good4U developed a unique 'Super Sprouts' mix that features a combination of brocco sprouts and super shoots. The company's products are crafted from plant-based ingredients, ensuring they are free from additives and preservatives, and are designed to meet the dietary needs of health-conscious consumers, including athletes. Good4U focuses on providing high-quality, nutritious food options at reasonable prices, making healthy eating accessible to a wider audience.
SyncroPhi Systems
Seed Round in 2013
SyncroPhi Systems Ltd. is a medical device company located in Galway, Ireland, specializing in the development and commercialization of advanced wireless patient-monitoring systems. Founded in 2007, the company aims to enhance healthcare delivery in front-line settings across the European Union. Its flagship product, KEWS300, is a nursing software that provides healthcare professionals with accurate point-of-care information, facilitating real-time patient tracking and support. SyncroPhi Systems operates under an ISO 13485:2003 certified Quality Management System, ensuring that all products are designed and manufactured in compliance with relevant medical device regulations. The company is focused on improving patient care, optimizing patient flow, and enabling hospital research through its innovative solutions.
Kelsius
Venture Round in 2012
Kelsius is a provider of automation technology focused on product safety and compliance for the food services and healthcare sectors. Established in 2003 and headquartered in Donegal, Ireland, the company specializes in wireless temperature monitoring systems and digital HACCP management solutions. Kelsius's technology enhances product safety and ensures adherence to regulatory standards while also optimizing costs related to these processes. By reducing product wastage linked to refrigeration failures and improving food quality, Kelsius empowers its clients to achieve significant cost savings and labor efficiencies through automation.
Marvao Medical
Venture Round in 2011
Marvao Medical Devices, Ltd. is a company focused on the development, manufacturing, and marketing of medical devices aimed at reducing the risk of catheter-related bloodstream infections. The company specializes in creating implantable devices that manage the exit sites of central venous catheters, providing patients with a natural barrier at these critical access points. By addressing the challenges associated with long-term vascular access, Marvao Medical seeks to enhance patient safety and improve health outcomes in individuals requiring extensive catheter use.
FMC-Tech
Funding Round in 2010
FMC-Tech Ltd, established in August 2001, specializes in developing network management systems for medium voltage overhead electricity networks. The company's flagship product, the Crystal System, is designed to enhance network performance and address regulatory requirements. By delivering network intelligence, FMC-Tech aims to improve customer satisfaction while simultaneously reducing operational costs. The system provides a comprehensive solution to meet the evolving demands of the electricity sector, ensuring that businesses can effectively manage their networks in a cost-efficient manner.
Touch Ltd., a software company, provides integrated and unified audio visual and information technology convergence solutions. It offers 3touch ENTERPRISE, a client server based multimedia solution that stores, manages, and controls various presentation and multimedia materials, as well as allows access to and play-out that information; and 3touch Media Editor software, which helps to develop a digital signage playlist. The company also provides 3touch Room Control, a system designed to link to various legacy control solutions and interact with existing or new installs; and 3touch TV network, a video delivery and display system that plays live video either on demand or according to a preset schedule. In addition, it offers 3touch Encoding, which provides various ways to get the live stream on the network; and 3touch Video on Demand Module, a system that streams content through a set-top box, allows viewing in real time, or allows watching it through a software player. Te company’s solutions are used in various audio visual areas, such as presentation and content management and delivery, interactive whiteboard applications, room control, room booking and management system, automated video conferencing scheduling and setup, equipment and personal computer monitoring, and IPTV/ video on demand and digital signage. 3Touch Ltd. was founded in 2003 and is headquartered in Athlone, Ireland with additional offices in Cambridge, the United Kingdom.
Lightstorm Networks
Series A in 2006
Lightstorm Networks designs, develops, and supplies semiconductor solutions. It provides hardware and software subsystems. The company's products include Brooklyn-10 Carrier Ethernet Switch, a layer 2 switch with an integrated 20G traffic manager; Solas Software Suite, a carrier Ethernet software development platform, including APIs, drivers, and development tools; and B-10 Development Platform, a 3RU development system that demonstrates the functionality of the Brooklyn-10 and partner silicon solutions. Its products are used in multiservice provisioning platform, wireless backhaul, document library, and carrier Ethernet switch and router applications.